Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of organic compounds known as 3‑alkylindoles, specifically an indole derivative with a dimethylaminomethyl substituent at position 3 and a propan‑1‑ol group at position 7. It has the molecular formula C14H20N2O and is not approved for medical use in any jurisdiction. The compound has been studied structurally as a ligand for group IIE secretory phospholipase A2, suggesting it may act as an inhibitor or modulator of this enzyme, but there are no clinical trials or approved indications. Its primary relevance appears to be experimental and structural biology research[1][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-{3-[(dimethylamino)methyl]-1H-indol-7-yl}propan-1-ol.